RUMI Scientific announces Receipt of Two-Year Phase II SBIR Award totaling $1.9 Million to Accelerate Discovery and Development of Novel Therapeutic Candidates for the Treatment of Autism

RUMI Scientific, Inc. announced it has received a Phase II Small Business Innovation Research grant from the National Institutes of Mental Health totaling $1.9 MM. RUMI’s organoid platform utilizes an unbiased phenotypic approach to target drug discovery for CNS and other diseases.